Genomic alterations to predict response to irinotecan-based chemotherapy in metastatic colorectal cancer.

被引：0
|
作者：
De La Fouchardiere, Christelle
Jiang, Xiaojun
Pissaloux, Daniel
Seigne, Christelle
Wang, Qing
Desseigne, Francoise
Fondrevelle, Marie-Eve
Cassier, Philippe Alexandre
Attignon, Valery
Combaret, Valerie
Perol, David
Tredan, Olivier
Blay, Jean-Yves
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
[2] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
586
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Hesketh, Paul J.
    Bosnjak, Snezana M.
    Nikolic, Vlada
    Rapoport, Bernardo
    SUPPORTIVE CARE IN CANCER, 2011, 19 (12) : 2063 - 2066
  • [42] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Paul J. Hesketh
    Snezana M. Bosnjak
    Vlada Nikolic
    Bernardo Rapoport
    Supportive Care in Cancer, 2011, 19
  • [43] Epidermal Growth Factor Receptor Expression Discrepancies in Metastatic Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan-Based Chemotherapy Refractory to Irinotecan and Oxaliplatin
    Han, Hye-Suk
    Chang, Hee Jin
    Hong, Yong Sang
    Kim, Sun Young
    Lee, Keun Seok
    Jung, Kyung Hae
    DISEASES OF THE COLON & RECTUM, 2009, 52 (06) : 1144 - 1151
  • [44] Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy
    Lee, Duk Joo
    Lee, Jeeyun
    Lee, Ha Yeon
    Lim, Taekyu
    Lee, Su Jin
    Yi, Seong Yoon
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    MEDICAL ONCOLOGY, 2011, 28 : S291 - S294
  • [45] Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy
    Kohei Shitara
    Satoshi Yuki
    Kentaro Yamazaki
    Yoichi Naito
    Hiraku Fukushima
    Yoshito Komatsu
    Hirofumi Yasui
    Toshimi Takano
    Kei Muro
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 595 - 603
  • [46] Premedication and incidence of infusion-related reactions in patients with metastatic colorectal cancer treated with cetuximab plus irinotecan-based chemotherapy
    Wilke, H.
    Siena, S.
    Loos, A. H.
    Berghoff, K.
    Kohne, C.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer
    Pliakou, Evangelia
    Lampropoulou, Dimitra Ioanna
    Dovrolis, Nikolas
    Chrysikos, Dimosthenis
    Filippou, Dimitrios
    Papadimitriou, Christos
    Vezakis, Antonios
    Aravantinos, Gerasimos
    Gazouli, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [48] Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy
    Duk Joo Lee
    Jeeyun Lee
    Ha Yeon Lee
    Taekyu Lim
    Su Jin Lee
    Seong Yoon Yi
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Young Suk Park
    Medical Oncology, 2011, 28 : 291 - 294
  • [49] Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy
    Shitara, Kohei
    Yuki, Satoshi
    Yamazaki, Kentaro
    Naito, Yoichi
    Fukushima, Hiraku
    Komatsu, Yoshito
    Yasui, Hirofumi
    Takano, Toshimi
    Muro, Kei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 595 - 603
  • [50] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Saltz, LB
    Cox, JV
    Blanke, C
    Rosen, LS
    Fehrenbacher, L
    Moore, MJ
    Maroun, JA
    Ackland, SP
    Locker, PK
    Pirotta, N
    Elfring, GL
    Miller, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 905 - 914
12345